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Abstract
There are no currently available disease-modifying pharmacological treatments for most of the chronic hereditary
ataxias; thus, effective rehabilitative strategies are crucial to help improve symptoms and therefore the quality of life.
We propose to gather all available evidence on the use of video games, exergames, and apps for tablet and smartphone
for the rehabilitation, diagnosis, and assessment of people with ataxias. Relevant literature published up to June 8, 2020,
was retrieved searching the databases PubMed, ISI Web of Science, and the Cochrane Database. Data were extracted
using a standardized form, and their methodological quality was assessed using RoB and QUADAS-2. Six studies of 434
retrieved articles met the predefined inclusion/exclusion criteria. Two of them were diagnostic, while 4 were experi-
mental studies. Studies included participants ranging from 9 to 28 in trials and 70 to 248 in diagnostic studies. Although
we found a small number of trials and of low methodological quality, all of them reported an improvement of motor
outcomes and quality of life as measured by specific scales, including the SARA, BBS, DHI, and SF-36 scores. The
main reason for such low quality in trials was that most of them were small and uncontrolled, thus non-randomized and
unblinded. As video games, exergames, serious games, and apps were proven to be safe, feasible, and at least as
effective as traditional rehabilitation, further and more high-quality studies should be carried out on the use of these
promising technologies in people with different types of ataxia.
Keywords Video games .Mobile applications . Technology . Rehabilitation . Ataxia . Systematic review
Background
Ataxia, or lack of voluntary coordination of muscle move-
ments, has an overall prevalence of around 26 per 100,000
in European pediatric population [1], 8.4 per 100,000 (95%
CI 7.2 to 11.6) for idiopathic late-onset cerebellar ataxia
(LOCA), and 1.8 per 100,000 (95%CI 0.8 to 2.7) for inherited
LOCA [2]. Based on the population living in Europe, we can
estimate about 525,000 cases in all ages (1300 in pediatric
population and 431,200 and 92,500 for idiopathic and
inherited LOCA, respectively) (https://ec.europa.eu/eurostat).
Ataxia is a common neurological sign that might be due to
several different neurological conditions, including brain
tumors, brain injuries, stroke, infections (e.g., varicella),
toxicity, or genetic causes. Its evolution can be acute,
subacute, episodic, or chronic, with the latter including both
progressive and non-progressive forms. The diagnosis of the
underlying cause is a crucial step, and might be a long process
in case of chronic or episodic ataxias, due to the rarity and
complexity of these conditions [3]. Cerebellar ataxia is typi-
cally among the core features of these diseases, affecting mo-
tor skills, eye movements, balance, and coordination, thus
significantly affecting activities of daily living (ADL). In
some hereditary conditions, ataxia is part of a multisystem
dysfunction, which may cause intellectual disability and/or
other neurological symptoms, spine deformities such as
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scoliosis, and/or several other disorders affecting different or-
gans (e.g., cardiomyopathy, congenital cataracts, optic nerve
atrophy, retinal dystrophy, and deafness) [4–8].
There are no currently available disease-modifying phar-
macological treatments for most of the chronic hereditary
ataxias, thus effective rehabilitative strategies are crucial to
improve symptoms and therefore the quality of life [9].
Rehabilitative and physiotherapeutic interventions are in-
creasingly being tested in clinical studies for the treatment of
people with different ataxias. Previous studies showed that
treatments based on demanding gait and balance tasks can
increase postural stability and lead to reduce the dependency
of patients on walking aids, thus increasing their indepen-
dence in ADL [10–13].
Non-ambulant patients with more severe ataxias were also
shown to benefit from locomotion and treadmill training with
or without body weight support [9].
In this framework, some recent studies have shown that the
use of some virtual reality tools can be effective for the treat-
ment of people with progressive ataxias [14]. Virtual reality is
often incorporated within exergames, which are video games
designed as easier, more entertaining, and more appealing
exercise tools compared to usual, traditional, training systems.
Exergaming is defined as technology-driven physical activi-
ties, such as video game play, that requires participants to be
physically active or exercise in order to play the game [15].
Exergames usually include coordination and balance tasks
and are specifically structured to enhance the participation
and adhe rence o f the p laye r /pa r t i c ipan t to the
game/intervention. As rehabilitation for people with ataxia
can be challenging, these games could be an extremely pow-
erful and useful tool to improve rehabilitative interventions in
these patients [16]. As exergames are usually extremely en-
joyable and easy to play, do not require the constant presence
of a trainer to monitor the activity, and are usually easily
available and not very expensive, including these type of
games in the rehabilitation program could also help moving
the whole intervention, or part of it, from a clinical setting to a
home setting, and could help to turn a rehabilitation session
into more enjoyable activities, particularly in children.
Moreover, the use of exergames could help to reach a higher
number of patients by minimizing the access to the health
system, as patients could be able to follow the whole rehabil-
itation program, or even part of it, at home.
Exergames have been proven as effective in improving
motor and cognitive symptoms in several neurological and
neurodegenerative diseases [17, 18]. A relatively recent sys-
tematic review [19] concluded that consistent evidence sup-
ports the effectiveness of rehabilitation in improving motor
function, ataxic symptoms, and balance in patients with
chronic ataxias, including rehabilitation using serious games
and exergames. Furthermore, the therapeutic use of commer-
cially available exergame systems and applications for
smartphones and tablets can be very cost-effective and im-
prove quality of life and social inclusion, minimizing the per-
ception of disability. However, no systematic reviews nor
meta-analyses are currently available on the effectiveness of
this kind of technology specifically in patients with chronic
ataxias. For all these reasons, we deemed it relevant to review
all existing evidence on the use of this technology in patients
with ataxias. Therefore, the objective of this review was to
gather, qualitatively assess, and summarize the results, both
narratively and through a meta-analysis, from all available
evidence on the use of video games, exergames, and apps
for tablet and smartphone for the rehabilitation, diagnosis,
and assessment of people with ataxias.
Methods
This systematic review was carried out according to the meth-
odology reported in the Cochrane Handbook for Systematic
Reviews [20] and followed the PRISMA statement for
reporting systematic reviews and meta-analyses [21, 22]. A
structured bibliographic search was performed on the data-
bases PubMed, ISI Web of Science, and the Cochrane
Database of Systematic Reviews using the following search
terms: (“app” OR “apps” OR “smar tphone” OR
“smartphones” OR “smart-phone” OR “smart-phones” OR
“smart phone”OR “smart phones”OR “tablet*”OR “mobile”
OR “game” OR “kinect” OR “nintendo” OR “games” OR
“gaming” OR exergam* OR “virtual reality” OR “augmented
reality”) AND (*ataxi* OR “joubert*”). No limitations were
applied for date of publication, study design, nor language.
The bibliographic references of selected studies were also
browsed to identify further possibly relevant literature. Two
independent reviewers (EL, PP) initially selected studies
based on their pertinence with and relevance to the topic of
the review. Disagreements were solved by discussion or by a
third independent reviewer (NV). Relevant literature pub-
lished up to June 8, 2020, was retrieved searching the data-
bases. Selected studies were retrieved in full text, and the
following predefined inclusion/exclusion criteria were ap-
plied.We only included (1) experimental and/or observational
studies; (2) studies that reported data on the use of technolo-
gies such as computer games, gaming consoles, tablet or
smartphone apps, and/or devices for augmented or virtual re-
ality for the rehabilitation and/or treatment of people with
ataxia; (3) studies that enrolled people with ataxia of any age
class; (4) studies that enrolled patients with any type of ataxia;
and (5) studies that reported enough information and data to
allow for an adequate quality assessment and a summary of
evidence. We excluded (1) conference proceedings, letters,
abstracts, editorials, narrative reviews, systematic reviews,
meta-analyses, case-reports, or case-series; and (2) studies
reporting only narrative or non-quantifiable results.
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Systematic reviews were not included, but were anyway se-
lected and analyzed to search their bibliographies, and to
check for consistency of results.
The methodological quality of all included studies was
assessed by 3 independent reviewers (PP, EL, GB) using
The Cochrane Collaboration’s tool for assessing risk of bias
(RoB)in randomized trials [23], and the QUADAS-2 tool for
diagnostic studies [24]. The RoB tool includes seven specific
domains aimed at assessing selection bias, performance bias,
detection bias, attrition bias, reporting bias, and other potential
sources of bias, and requires that enough details are provided
to adequately assess the risk of bias, which is defined as “low
risk,” “high risk,” or “unclear risk.” The QUADAS-2 tool
includes 4 domains analyzing the adequateness of the meth-
odology adopted for patient selection, the choice and manage-
ment of the index test and the reference standard, and the flow
and timing with which the tests were administered. It includes
also an assessment of concerns about applicability for 3 of the
considered domains (i.e., patient selection, index test, refer-
ence standard). The tool does not allow for a global scoring,
but it provides an overall rating of high, unclear, or low risk of
bias for each domain, and an overall rating of high, unclear, or
low concern for applicability for the 3 considered domains.
Further potential bias or methodological flaws were also ad-
dressed. As neither of the tools provides a method to calculate
an overall quality score, we calculated it for both scales. For
the RoB tool, the overall score was calculated by summing the
number of items scored as “low risk of bias,” thus having an
overall score ranging from 0 to 7, with higher scores indicat-
ing higher quality. For the QUADAS-2 tool, the score was
calculated by summing the number of items scored as “low
risk of bias” or “low applicability concern,” thus obtaining an
overall score ranging from 0 to 7, with higher scores indicat-
ing higher quality.
Data extraction was performed by 3 independent reviewers
(GB, PP, EL), and data were summarized in specifically de-
signed standardized forms. Disagreements were resolved by
discussion between the reviewers.
Due to a high heterogeneity, a meta-analysis was carried
out using data from the only 2 experimental studies reporting
results for the same outcomemeasure. The summary tables for
the qualitative assessment and the meta-analysis were per-
formed using the software RevMan version 5.3 provided by
the Cochrane Collaboration.
Results
A total of 661 records were retrieved through the bibliograph-
ic searches. No articles were retrieved by browsing the refer-
ences of included studies. No systematic reviews nor meta-
analyses were available on this topic. Of the studies retrieved
through bibliographic searches, 7 studies were selected based
on their relevance and pertinence to the topic of the review.
Full texts were gathered and, after applying the predefined
inclusion and exclusion criteria, only 6 studies were included
in the review. One study was excluded, as it was a letter to the
editors reporting preliminary data on 1 patient who was sub-
sequently enrolled in the study published in 2017 by Schatton
et al. [25].
The flow diagram of literature is reported in Fig. 1.
Qualitative Assessment of Included Studies
Four studies were experimental studies, with 1 controlled trial
[26] and 3 single-group trials [27–29]. Two studies were cat-
egorized as diagnostic studies [30, 31].
All included experimental studies investigated the effec-
tiveness of either available video games for both Nintendo
Wii and Microsoft Xbox Kinect [27–29] or specifically devel-
oped exergames adopting the Kinect sensor in both children
and adults with different ataxias [26].
The 2 diagnostic studies evaluated the accuracy of either an
already available serious game coupled with the Kinect sensor
[30] or a specifically developed app for tablet and smartphone
[31] to assess motor symptoms in patients with ataxias, and to
discriminate between healthy subjects and patients with
ataxias.
A summary of the results, main characteristics, and quality
of included studies is reported in Table 1.
The overall methodological quality of all included studies
was medium-low, with 1 trial reaching a score of 4 [26], 2
trials having a score of 3, 1 trial having a score of 1 [29], and
both diagnostic studies having a score of 4.
The main reason for low scores in trials was that 3 studies
did not include a control group [27–29]; thus, patients were
not randomized nor blinded. All trials included small samples
(ranging from 9 to 28 participants), and the only randomized
study [26] applied a block randomization in 9 subjects, thus
leading to significant differences (e.g., Walking speed, Nine-
hole peg test) in the characteristics of subjects between the
experimental and the control group. Moreover, 1 trial [29]
reported and analyzed data in an unclear way, leading to a
high risk of incomplete and selective reporting (e.g., means
and ICs are not reported). However, ataxias are relatively rare
conditions, the technologies tested are difficult to standardize,
and it is relatively difficult to blind participants to them.
The main risk of bias in diagnostic studies was that they
were designed as case-control studies, thus the reference stan-
dard was carried out before the index test, and raters were not
blind to the diagnoses. However, the technology adopted was
objective; thus, the risk of interpreting results in an altered
way due to the knowledge of the diagnosis is relatively low.
Both trials enrolled small samples of selected patients (e.g.,
from a consortium), and one study enrolled subjects with dif-
ferent diagnoses. As previously stated, ataxias are relatively
Cerebellum
rare diseases, thus enrolling a large number of consecutive or
random subjects might be very difficult.
A summary of the qualitative assessment of all included
studies is reported in Fig. 2 for diagnostic studies and Fig. 3
for trials.
As for the included trials, a high heterogeneity was ob-
served in the characteristics of the populations enrolled, in
the type of interventions used, and in the outcomes
considered.
Three studies included participants aged < 18 years, while
1 included only adult subjects. Age ranges were extremely
heterogeneous, with 1 study enrolling subjects aged 11–20
[28], 1 enrolling subjects aged 15 to 70 [29], 1 including
subjects aged 6–29 [27], and 1 including adults aged 51–60
[26].
All 4 trials used exergaming for the rehabilitation of both
adults and children with different types of ataxia, and all
employed commercially available consoles and video games.
Specifically, 1 study used the Nintendo Wii [29], 1 used the
XboxKinect [28], 1 used both the NintendoWii and the Xbox
Kinect [27], and 1 used the Kinect sensor along with a specific
exergame program [26].
Only 1 study included a control group treated with conven-
tional training [26]; all the remaining studies were based on
“inter-subject” control, meaning that they compared perfor-
mances pre- and post-training.
Three trials used the SARA score as their primary outcome
measure, while 1 used the Dizziness Handicap Inventory
(DHI), the Berg Balance Scale (BBS), and the Short-Form
36-Items (SF-36) scores as outcome measures [29].
Considering the relative homogeneity of the outcome measure
in three trials, we attempted a meta-analysis of the mean
change from baseline to post-training in the SARA score.
However, 1 trial [26] did not report the mean scores and SD
pre- and post-training; thus, we excluded it from the meta-
analysis. Means and SDs of the remaining 2 trials [27, 28]
were calculated using the individual patient data reported in
the studies, and for 1 of the trials, post-test scores [28] were
extracted from the provided graph (Fig. 4).
Description of Included Studies
The study by Wang et al., the only controlled study [26],
was a pilot trial enrolling 9 subjects with spinocerebellar
ataxia (SCA) type 3 aged 51 to 60 years (mean age 54)
randomized to either exergaming with Kinect sensor or to
conventional balance and coordination training. The exper-
imental group (n = 5) followed 3 sessions of 40-min per
Fig. 1 Flow diagram of the
literature
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week for 4 weeks of an exergaming program intervention (a
specifically designed game including a reaching task, a
pointing task, a following task, and an avoiding task) using
a Kinect sensor. Results showed a median decrease in the
SARA score of − 30.0% (range − 42.9–− 25.0) in the
exergaming group and − 16.8% (− 33.3–− 8.3) in the con-
trol group, with a reduction up to − 50% of the gait-posture
subscore in the exergaming group.
Among non-controlled studies, the trial by Santos et al., the
largest one [29], which was also the one with the lowest qual-
ity score, enrolled 28 subjects with undefined SCA (n = 7),
SCA3 (n = 5), SCA10 (n = 5), SCA2 (n = 2), SCA4 (n = 1),
and autosomal-recessive cerebellar ataxia (ARCA) (n = 8).
All subjects underwent a therapeutic body-balance training
for vestibular rehabilitation using the Nintendo Wii hand-
held remote andWii balance board with 4 commercially avail-
able balance games (Soccer heading, Table tilt, Tightrope
walk, Ski slalom). Results report an improvement in balance,
measured with the Berg Balance Scale (BBS), and in dizzi-
ness, measured with the Dizziness Handicap Inventory (DHI).
However, data are not clearly reported in the publication and
crude values pre- and post-training for each outcome measure
are not detailed.
The study by Schatton et al. [27], another non-controlled
trial, enrolled 11 subjects diagnosed with Friedreich ataxia
(FA) (n = 5), ataxia telangiectasia (n = 3), autosomal-
recessive ataxia with no identified genetic cause (n = 2), or
ataxia with oculomotor ataxia type 1 (n = 1). All participants
underwent 12 weeks of coordinative training with Nintendo
Wii and Xbox Kinect using commercially available video
games. The study used the SARA score as the main outcome
measure, and reported a significant short-term (at 6 weeks;
p < 0.002) and long-term (at 12 weeks; p < 0.006) improve-
ment in the overall SARA score from baseline to post-training,
mainly driven by improvements in posture and gait.
The study by Ilg et al., the smallest of the non-controlled
trials [28], enrolled 10 patients with FA (n = 4), ataxia with
oculomotor ataxia type 1 (n = 1), and autosomal-recessive
(n = 3) and autosomal-dominant (n = 2) ataxia without genetic
diagnosis. All patients underwent an 8-week video game–
based coordination training using 3 commercially available
Microsoft Xbox Kinect games (Table tennis; Light race;
20,000 Leaks). The study used the SARA score as the primary
outcome measure, with results showing a significant short-
term (at 2 weeks; p < 0.02) and long-term (at 8 weeks;
p < 0.001) improvement in the overall score from baseline to
post-training, mainly due to an improvement in posture (p =
0.0003). Results also showed a significant improvement in the
overall dynamic balance (p = 0.01).
As for diagnostic studies, the study by Arcuria et al., the
largest one [31], enrolled 87 patients affected by FA (n = 36),
SCA1 (n = 9), SCA2 (n = 6), myoclonic epilepsy with ragged
red fibers (MERRF) (n = 3), SCA3 (n = 2), SCA8 (n = 2),
autosomal-recessive spastic ataxia of Charlevoix-Saguenay
Fig. 2 Results from the risk of bias assessment of included diagnostic studies. a Summary table of the assessment for each item for each study. b Graph
plotting the distribution of assessments across studies for each item
Cerebellum
(ARSACS) (n = 1), autosomal-recessive ataxia type 8
(SCAR8) (n = 1), multiple system atrophy-cerebellar type
(MSA-C) (n = 1), or CA with no defined genetic diagnosis
(n = 26), as well as 170 sex- and age-matched healthy sub-
jects. All participants were tested with the 15-White Dots
APP-Coo-Test (15-WDACT), an application specifically de-
veloped for tablets-PC, as index test, and the Nine-hole peg
test (9HPT) and Click Test as reference standards. In healthy
subjects, results showed no significant differences based on
gender, while a significant difference in the mean execution
time between the 18–45 age class and the 46–75 age class was
reported (p < 0.001). In patients, 15-WDACT execution time
increased along with disease severity (R = 0.91), and a high
correlation was observed between measurements obtained
with the 15-WDACT and the scores obtained with the 9HPT
and Click Test. Moreover, results showed a high intra-rater
reliability, accuracy, and internal consistency.
The study by Bonnechere et al., the smaller study classified
as diagnostic [30], enrolled 27 patients with FA and 43
healthy subjects. All subjects participated in 3 sessions of a
specifically designed mini-game (Wipe Out game), with spa-
tial displacement recorded by a Kinect sensor. Highly signif-
icant differences were observed for time and accuracy of ex-
ecution between patients and controls (both p < 0.001).
Among patients, significant correlations were observed be-
tween age and time of execution (p = 0.015) and accuracy
Fig. 3 Results from the risk of
bias assessment of included
RCTs. a Summary table of the
assessment for each item for each
study. b Graph plotting the
distribution of assessments across
studies for each item
Fig. 4 Results from the meta-analysis of the subgroup of homogeneous studies
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(p = 0.004), as well as between age at diagnosis and speed-
related parameters (p = 0.021). A significant correlation was
also observed between the Nine-hole peg test and the total
displacement of the upper limbs (p = 0.012), the area covered
(p = 0.025), the amplitudes of movements (mediolateral dis-
placement p = 0.041; top-down displacement p = 0.033).
Moreover, a statistically significant correlation was found be-
tween disease duration and decreased speed (p = 0.002),
which was associated with a significant reduction in accuracy
(p = 0.001).
Discussion
In this review, we assessed currently available evidence on the
use of new mobile and gaming technologies in the assessment
and rehabilitation of people with chronic ataxias. Six studies
were included in the systematic review, enrolling a number of
participants ranging from 9 to 28 in trials and from 70 to 248
in diagnostic studies. The wide difference in the sample sizes
between the 2 types of study might be due to the fact that
treating a patient within a structured rehabilitative intervention
is extremely more challenging in terms of resources than
assessing a motor feature. Two of the included studies were
diagnostic, while 4 were experimental studies. Although we
found a small number of trials and despite their low method-
ological quality, all of them reported an improvement of motor
outcomes and quality of life as measured by specific scales,
including the SARA, BBS, DHI, and SF-36 scores. The main
reason for such low quality in trials was that most of them
were small and uncontrolled, thus non-randomized and un-
blinded. Ataxias are rare diseases, thus enrolling large samples
can be extremely challenging. In addition, a group of patients
cannot be eligible for rehabilitation protocols based on gaming
and virtual or augmented reality, due to the wide range of
comorbidities potentially associated with ataxia. Among
these, visual loss, hearing disturbances, intellectual disability,
and predominant non-ataxia movement disorders (e.g., spas-
ticity, chorea, Parkinsonism) are usually considered exclusion
criteria [27–29].Moreover, managing a rehabilitative study on
patients that, though having the same diagnosis may have
widely different phenotypic variants and peculiarities, might
be very difficult. However, adopting a multicenter approach
and involving organizations of ataxic patients could allow
enrolling a larger number of participants, increasing the size
of subgroups with homogeneous phenotypes.
We found only 2 diagnostic studies investigating the use of
these technologies for the assessment of specific motor func-
tions in people with chronic ataxias. Though having an overall
low-quality score, they both reported these tools to be useful
and reliable. The low quality of these studies was mainly due
to their being designed as case-control diagnostic studies and
the enrollment of subjects with different diagnoses, disease
duration, and degree of severity. The rarity of the disease,
however, makes it virtually impossible to design conventional
diagnostic studies.
Overall, a wide heterogeneity was observed across includ-
ed studies in the participants enrolled, the type of technologies
applied, and the outcome measures adopted. This prevented a
direct comparison and a cumulative analysis of results. Some
studies enrolled patients with different types of ataxias, differ-
ent age classes, and different levels of severity of symptoms.
Only 2 studies used the same technologies, with the same
outcome measures. As a result, it is difficult to draw general
conclusions on the most appropriate approach and the optimal
age of intervention for the investigated diseases.
An additional limitation is that all included studies enrolled
participants with progressive (degenerative) ataxias, mostly
characterized by cerebellar atrophy and a progressively dis-
abling course. None of the studies included patients with non-
progressive forms, which are typically associated with
midbrain-hindbrain malformations (mostly cerebellar hypo-
plasia and/or dysplasia of variable severity, either isolated or
associated to other brainstem defects) [32, 33]. Considering
the almost stable course of neurological impairment associat-
ed with non-progressive ataxias, it is reasonable to expect a
greater and more durable effectiveness of gaming-based reha-
bilitation in this kind of patients. However, further targeted
studies are needed to address this issue.
Video games, exergames, serious games, and apps were
proven to be safe, feasible in patients with Parkinson’s dis-
ease, and at least as effective as traditional rehabilitation [34]
specifically in improving balance and fatigue [35], and they
also appear to be promising tools in the treatment of children
with cerebral palsy [36]. Therefore, further, and more high-
quality, studies should be carried out on the use of these tech-
nologies in people with different types of ataxia. The ideal
study to investigate the efficacy and/or effectiveness of any
type of interventions would be a randomized, controlled trial.
To minimize bias, trials should include a large sample of con-
secutive patients and randomize them to either treatment or
placebo/usual care in a blinded fashion.Maintaining the blind-
ness of both participants and the staff administering the treat-
ment, however, can be impossible, in rehabilitative trials; thus,
usually the blindness of the personnel assessing the outcomes
should be at least guaranteed. Therefore, additional larger,
multicenter randomized controlled trials should be carried
out with the objective of providing more structured evidence
of the potential efficacy and effectiveness of exergaming in
the rehabilitation of children and adults with ataxia.
Conclusion
Results from the included studies were inconclusive, as there
was a wide heterogeneity in the considered outcomes and in
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the type of games and technology adopted; thus, results, ex-
cept for two studies, could not be aggregated nor directly
compared. However, games and apps appeared to be promis-
ing in improving the motor symptoms and quality of life of
patients with ataxias, or in testing specific types of symptoms.
Therefore, as video games, exergames, serious games, and
apps were proven to be safe, feasible, and at least as effective
as traditional rehabilitation tools in patients with neurodegen-
erative diseases, further and more high-quality studies should
be carried out on the use of these promising technologies in
people with different types of ataxia.
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